These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 574733)

  • 21. Antagonism of pancuronium- and pipecuronium-induced neuromuscular block.
    Gyermek L; Cantley EM; Lee C
    Br J Anaesth; 1995 Apr; 74(4):410-4. PubMed ID: 7734260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potencies of edrophonium and neostigmine as antagonists of pancuronium.
    Breen PJ; Doherty WG; Donati F; Bevan DR
    Anaesthesia; 1985 Sep; 40(9):844-7. PubMed ID: 4051150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of pancuronium in renal failure: no recurarization.
    Bevan DR; Archer D; Donati F; Ferguson A; Higgs BD
    Br J Anaesth; 1982 Jan; 54(1):63-8. PubMed ID: 6275872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
    Ferguson A; Egerszegi P; Bevan DR
    Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired neostigmine antagonism of pancuronium during enflurane anaesthesia in man.
    Delisle S; Bevan DR
    Br J Anaesth; 1982 Apr; 54(4):441-5. PubMed ID: 7066141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog.
    Hennis PJ; Cronnelly R; Sharma M; Fisher DM; Miller RD
    Anesthesiology; 1984 Nov; 61(5):534-9. PubMed ID: 6149707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of halothane and enflurane on the reversibility of an Org NC45 neuromuscular blockade in cats.
    Booij LH; Crul JF; van der Pol F
    Anasth Intensivther Notfallmed; 1982 Apr; 17(2):78-80. PubMed ID: 6124173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of pancuronium neuromuscular blockade in halothane-anesthetized ponies using neostigmine and edrophonium.
    Hildebrand SV; Howitt GA
    Am J Vet Res; 1984 Nov; 45(11):2276-80. PubMed ID: 6524720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antagonism to neuromuscular effect of subcutaneous administration of pancuronium by neostigmine].
    Iwasaki H; Igarashi M; Omori H; Omote K; Namiki A
    Masui; 1994 Jun; 43(6):885-8. PubMed ID: 8072147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine.
    Miller RD; Larson CP; Way WL
    Anesthesiology; 1972 Nov; 37(5):503-9. PubMed ID: 4263447
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of hypocarbia and hypercarbia on the antagonism of pancuronium-induced neuromuscular blockade with neostigmine in man.
    Wirtavuori K; Salmenperä M; Tammisto T
    Br J Anaesth; 1982 Jan; 54(1):57-61. PubMed ID: 6275871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine.
    Donati F; McCarroll SM; Antzaka C; McCready D; Bevan DR
    Anesthesiology; 1987 Apr; 66(4):471-6. PubMed ID: 3565812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incomplete reversal of pancuronium neuromuscular blockade by neostigmine, pyridostigmine, and edrophonium.
    Bartkowski RR
    Anesth Analg; 1987 Jul; 66(7):594-8. PubMed ID: 3605668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cumulative dose responses to gallamine, pancuronium, and neostigmine in halothane-anesthetized horses: neuromuscular and cardiovascular effects.
    Klein L; Hopkins J; Beck E; Burton B
    Am J Vet Res; 1983 May; 44(5):786-92. PubMed ID: 6869984
    [No Abstract]   [Full Text] [Related]  

  • 37. Neostigmine antagonism of succinylcholine phase II block: a comparison with pancuronium.
    Futter ME; Donati F; Sadikot AS; Bevan DR
    Can Anaesth Soc J; 1983 Nov; 30(6):575-80. PubMed ID: 6315193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical studies on Org NC 45: comparison with pancuronium.
    Kerr WJ; Baird WL
    Br J Anaesth; 1982 Nov; 54(11):1159-65. PubMed ID: 6128012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atropine-neostigmine mixture: a dose-response study.
    Naguib M; Gomaa M
    Can J Anaesth; 1989 Jul; 36(4):412-7. PubMed ID: 2758540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.